Table 3.

Summary of Articles that Examined Outcomes Associated with Cost Communication

Author (year), Country	Population and Characteristics	Site	Sample Size	Costs Discussed, %	Outcome	Notes
Kelly et al (2015),17 USA	- Previously treated metastatic breast, lung, or colorectal cancer patients - 51.1% annual household income > $60,000 - 100% insured	single institute	96	28%	Satisfaction: 81.2% had no negative feelings or conflicts when discussing costs with providers	- patients recruited through participating physicians - patient satisfaction measured using Satisfaction with Decision Scale - data collected using questionnaire
Bestvina et al (2014),13 USA Zafar et al (2015),14 USA	- adults receiving anticancer therapy - 80% income > $60,000 - 100% insured, 56% private	1 academic cancer center+3 affiliated rural oncology clinics	300	19%	Non-adherence: higher odds of non-adherence with cost discussion [OR=2.58, 95% CI, 1.14 to 5.85] OOP costs: 57% lower costs due to cost discussions	- convenience sample from participating sites - focused on OOP costs - 27% nonadherence, self-reported - data collected via in person interviews at baseline and 3-month in person or phone follow-up

NOTE: OOP: out-of-pocket; OR: odds ratio; CI: confidence interval